Skip to main content

Animations

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.


  • Default content image

    Clinical Trial Site in Boca Raton About to Join PPMI

    A clinical trial site in Boca Raton is about to join the Foundation’s PPMI study, and already, the site is getting media coverage.
    Learn more

  • Default content image

    New Study Protocol incorporating following subjects with SWEDD now posted

    An updated protocol has been posted to the PPMI site. This is the 3rd amendment to the protocol and incorporates a third cohort into the PPMI study.
    Learn more

  • Default content image

    Clinical Data and Biospecimens available for over 200 subjects

    We are pleased to announce that PPMI has now enrolled over 200 subjects.
    Learn more

  • Default content image

    PPMI Diffusion Tensor Imaging Sub-study One of the Largest Ever in Parkinson's disease

    In addition to collecting structural MRI data, seven PPMI sites will also be performing diffusion tensor imaging (DTI), an MRI technique that analyzes the movement of water molecules in brain tissue. 
    Learn more

  • Default content image

    The Department of Cures: It's us

    While there's no doubt that receiving a diagnosis of serious illness remains a life-changer, today, many patients can look forward to a much brighter prognosis, thanks to new and better…
    Learn more

  • Default content image

    Paracelsus-Elena Klinik featured in Hessische Allgemeine

    Kassel is once again a center for international research: The Paracelsus-Elena-Clinic is taking part in a study for the early detection and the progression of Parkinson’s disease.
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.